Current Roles

Employees:
151
Revenue:
$23.4M
About
Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today's therapies. Viridian's most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colo., with research and development operations in Waltham, Mass.
Viridian Therapeutics Address
221 Crescent Street
Boulder, CO
United States
Viridian Therapeutics Email

Past Companies

Viridian Therapeutics, Inc.Vice President, CMC
Intellia Therapeutics, Inc.Senior Director, External Manufacturing & Supply Chain
Intellia Therapeutics, Inc.Director, External Manufacturing & Supply Chain

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.